The transcript and protein abundances of several VAC-residing proteases were decreased in Δ<i>crt</i>. by L. Brock Thornton (6808385)

Subjects:

Supplementary Data from HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy by Michael F. Emmons (14935638)

Figure 1 from Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study by Clinton Yam (18716936)

(A) The distribution of mutations within the 3D structure of the TP53 protein. by Ashraf Attia Mahmoud (21262201)

Subjects:

The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. by Shuhuan Zhang (748003)

(A) Pie chart showing the distribution of mutation types identified within the TP53 gene. by Ashraf Attia Mahmoud (21262201)

Subjects:

Data Supplement from Selective Release of a Cyclopamine Glucuronide Prodrug toward Stem-like Cancer Cell Inhibition in Glioblastoma by Anaïs Balbous (3425822)

Figure 4 from PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells by Zachary A. Schaaf (12912100)

Supplementary Figures from Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell... by Chia-Wen Liu (708076)

Figure 3 from Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial by Santeri A. Pakola (19530073)

Figure 6 from PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells by Zachary A. Schaaf (12912100)

Figure 5 from PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells by Zachary A. Schaaf (12912100)

Data Sheet 1_Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology.docx by Alina Tscherne (8544519)

“…However, many important advancements have been made in terms of PUUV research over the last years. This included the elucidation of its glycoproteins, the discovery of broadly neutralizing hantavirus antibodies as therapeutic candidates and expanded research on the mRNA vaccine technology which will likely enable the development of strong PUUV vaccine candidates in the near future. …”

Figure S2 from Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer by Erika S. Dahl (15078264)

FIGURE 3 from Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme by Jason D. Lickliter (16676097)

supplementary figures from SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway by Claudia C.S. Chini (12509530)

Table S1 from A Short SOX9 Peptide Mimics SOX9 Tumor Suppressor Activity and Is Sufficient to Inhibit Colon Cancer Cell Growth by Philippe Blache (5847098)

Figure S4 from Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer by Erika S. Dahl (15078264)

Table_1_Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.docx by Zhihui Song (8270244)

Table_2_Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.docx by Zhihui Song (8270244)